7.32
price up icon5.48%   0.38
after-market Dopo l'orario di chiusura: 7.22 -0.10 -1.37%
loading
Precedente Chiudi:
$6.94
Aprire:
$7.45
Volume 24 ore:
264.53K
Relative Volume:
0.99
Capitalizzazione di mercato:
$160.02M
Reddito:
$52.55M
Utile/perdita netta:
$-23.69M
Rapporto P/E:
-7.7872
EPS:
-0.94
Flusso di cassa netto:
$-15.29M
1 W Prestazione:
+4.57%
1M Prestazione:
+5.02%
6M Prestazione:
+83.46%
1 anno Prestazione:
+267.84%
Intervallo 1D:
Value
$7.32
$7.45
Intervallo di 1 settimana:
Value
$6.7525
$7.45
Portata 52W:
Value
$1.78
$7.95

Exagen Inc Stock (XGN) Company Profile

Name
Nome
Exagen Inc
Name
Telefono
(760) 560-1501
Name
Indirizzo
1261 LIBERTY WAY, VISTA, CA
Name
Dipendente
209
Name
Cinguettio
@ExagenInc
Name
Prossima data di guadagno
2025-03-11
Name
Ultimi documenti SEC
Name
XGN's Discussions on Twitter

Confronta XGN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
XGN
Exagen Inc
7.32 151.71M 52.55M -23.69M -15.29M -0.94
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
466.71 161.42B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
197.89 135.99B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
540.68 42.78B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
119.47 33.01B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
194.24 31.85B 15.50B 1.33B 2.16B 7.34

Exagen Inc Stock (XGN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-08-05 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
2021-10-15 Ripresa Cowen Outperform
2021-04-15 Iniziato Canaccord Genuity Buy
2020-11-10 Iniziato KeyBanc Capital Markets Overweight
2020-10-08 Iniziato BTIG Research Buy
2020-06-02 Ripresa Cantor Fitzgerald Overweight
2019-10-14 Iniziato Cantor Fitzgerald Overweight
2019-10-14 Iniziato Cowen Outperform
2019-10-14 Iniziato William Blair Outperform
Mostra tutto

Exagen Inc Borsa (XGN) Ultime notizie

pulisher
10:25 AM

Craig-Hallum initiates coverage on Exagen stock with Buy rating By Investing.com - Investing.com Canada

10:25 AM
pulisher
09:50 AM

Craig-Hallum bullish on Exagen, initiates with a Buy - TipRanks

09:50 AM
pulisher
06:07 AM

What analysts say about Exagen Inc. stockExponential return rates - Autocar Professional

06:07 AM
pulisher
02:59 AM

Is Exagen Inc. a good long term investmentGame-changing capital returns - Autocar Professional

02:59 AM
pulisher
Jul 22, 2025

What drives Exagen Inc. stock priceFree Consultation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Exagen Inc. Stock Analysis and ForecastTremendous growth opportunities - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why Exagen Inc. stock attracts strong analyst attentionFree Stock Market Beginners Guide - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

What makes Exagen Inc. stock price move sharplyLong Term Safe Yield Focus - Newser

Jul 22, 2025
pulisher
Jul 18, 2025

Exagen Appoints Chas McKhann to Board of Directors - The Globe and Mail

Jul 18, 2025
pulisher
Jul 17, 2025

Exagen Inc. Appoints Chas McKhann to Board of Directors - AInvest

Jul 17, 2025
pulisher
Jul 17, 2025

Exagen Inc. Appoints Chas McKhann to Board of Directors | XGN St - GuruFocus

Jul 17, 2025
pulisher
Jul 17, 2025

Exagen appoints Chas McKhann to board of directors By Investing.com - Investing.com Nigeria

Jul 17, 2025
pulisher
Jul 17, 2025

Exagen appoints Chas McKhann to board of directors - Investing.com Australia

Jul 17, 2025
pulisher
Jul 17, 2025

Exagen Strengthens Board with Healthcare Veteran Behind Two Boston Scientific Acquisitions - Stock Titan

Jul 17, 2025
pulisher
Jul 16, 2025

Michael Mahler Joins Exagen as Chief Scientific Officer - Medical Product Outsourcing

Jul 16, 2025
pulisher
Jul 16, 2025

Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025 - GlobeNewswire

Jul 16, 2025
pulisher
Jul 15, 2025

How Exagen Inc. stock performs during market volatilityFree Risk Assessment Services - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Exagen Inc. Announces Second Quarter 2025 Financial Results Release Date - AInvest

Jul 15, 2025
pulisher
Jul 15, 2025

Exagen Inc. to Announce Q2 2025 Financial Results and Host Conference Call on July 29 - Nasdaq

Jul 15, 2025
pulisher
Jul 15, 2025

Exagen Schedules Q2 2025 Earnings: CEO and CFO to Present Before Market Opens July 29 - Stock Titan

Jul 15, 2025
pulisher
Jun 30, 2025

Exagen Inc.(NasdaqGM: XGN) added to Russell 3000E Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

Exagen Inc.(NasdaqGM: XGN) added to Russell Microcap Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 29, 2025

Exagen Insider Ups Holding During Year - Yahoo.co

Jun 29, 2025
pulisher
Jun 29, 2025

Exagen Inc. (XGN): Insider Confidence and Undervaluation Signal Buying Opportunity Ahead of Key Earnings - AInvest

Jun 29, 2025
pulisher
Jun 24, 2025

Exagen announces resale of up to 1.15M shares - MSN

Jun 24, 2025
pulisher
Jun 23, 2025

Exagen appoints Michael Mahler as CSO - TipRanks

Jun 23, 2025
pulisher
Jun 23, 2025

Exagen appoints Dr. Michael Mahler as chief scientific officer - Investing.com

Jun 23, 2025
pulisher
Jun 14, 2025

Analysts Issue Forecasts for Exagen FY2026 Earnings - Defense World

Jun 14, 2025
pulisher
Jun 14, 2025

Millennium Management LLC Sells 6,649 Shares of Exagen Inc. (NASDAQ:XGN) - Defense World

Jun 14, 2025
pulisher
Jun 11, 2025

Exagen Inc. Holds 2025 Annual Stockholder Meeting - TipRanks

Jun 11, 2025
pulisher
Jun 05, 2025

Northern Trust Corp Has $75,000 Position in Exagen Inc. (NASDAQ:XGN) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

XGN Set to Participate in Virtual Meeting on June 11 | XGN Stock News - GuruFocus

Jun 04, 2025
pulisher
May 31, 2025

Exagen Inc. (NASDAQ:XGN) Short Interest Update - Defense World

May 31, 2025
pulisher
May 30, 2025

Exagen stock soars to 52-week high, hits $7.2 amid robust gains By Investing.com - Investing.com South Africa

May 30, 2025
pulisher
May 29, 2025

Exagen stock soars to 52-week high, hits $7.2 amid robust gains - Investing.com Nigeria

May 29, 2025

Exagen Inc Azioni (XGN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
diagnostics_research WAT
$295.63
price up icon 2.84%
$137.82
price down icon 1.50%
diagnostics_research DGX
$170.48
price down icon 4.35%
diagnostics_research LH
$250.51
price down icon 0.62%
diagnostics_research MTD
$1,257.20
price up icon 3.14%
diagnostics_research IQV
$194.24
price up icon 3.66%
Capitalizzazione:     |  Volume (24 ore):